Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
9 900.00% $0.0001
America/New_York / 3 mai 2024 @ 13:19
FUNDAMENTALS | |
---|---|
MarketCap: | 847.20 mill |
EPS: | 0 |
P/E: | 0 |
Earnings Date: | May 14, 2024 |
SharesOutstanding: | 8 472 020 mill |
Avg Daily Volume: | 0.0002 mill |
RATING 2024-05-03 |
---|
A+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/17 | 1/18 | 2/18 | 3/18 | 4/18 | 1/19 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.0001 - 0.0001 ( +/- 0.00%) |
ATR Model: 14 days |